820209-02-7 Usage
Uses
Used in Pharmaceutical Industry:
(RS)-N-[1-(3-FLUOROPHENYL)ETHYL]METHYLAMINE is used as a precursor in the synthesis of various drugs and pharmaceutical products. Its structure and properties make it suitable for further chemical reactions and modifications, contributing to the development of new and innovative medications.
Used in Organic Synthesis:
(RS)-N-[1-(3-FLUOROPHENYL)ETHYL]METHYLAMINE is utilized in organic synthesis for the creation of other compounds and materials. Its amine functional group and unique structure enable it to participate in a variety of chemical reactions, expanding its applications in the synthesis of organic compounds.
Used in Chemical Research:
(RS)-N-[1-(3-FLUOROPHENYL)ETHYL]METHYLAMINE may have potential applications in chemical research, where its properties and reactivity can be studied and harnessed for the advancement of scientific knowledge and the development of new chemical processes.
Check Digit Verification of cas no
The CAS Registry Mumber 820209-02-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,2,0,2,0 and 9 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 820209-02:
(8*8)+(7*2)+(6*0)+(5*2)+(4*0)+(3*9)+(2*0)+(1*2)=117
117 % 10 = 7
So 820209-02-7 is a valid CAS Registry Number.
InChI:InChI=1/C9H12FN/c1-7(11-2)8-4-3-5-9(10)6-8/h3-7,11H,1-2H3
820209-02-7Relevant academic research and scientific papers
Tackling N-Alkyl Imines with 3d Metal Catalysis: Highly Enantioselective Iron-Catalyzed Synthesis of α-Chiral Amines
Blasius, Clemens K.,Gade, Lutz H.,Heinrich, Niklas F.,Vasilenko, Vladislav
, p. 15974 - 15977 (2020/07/04)
A readily activated iron alkyl precatalyst effectively catalyzes the highly enantioselective hydroboration of N-alkyl imines. Employing a chiral bis(oxazolinylmethylidene)isoindoline pincer ligand, the asymmetric reduction of various acyclic N-alkyl imines provided the corresponding α-chiral amines in excellent yields and with up to >99 % ee. The applicability of this base metal catalytic system was further demonstrated with the synthesis of the pharmaceuticals Fendiline and Tecalcet.
TACHYKININ RECEPTOR ANTAGONISTS
-
Page 29, (2010/02/10)
The present invention relates to selective NK-1 receptor antagonists of Formula (I) or a pharmaceutically acceptable salt thereof, for the treatment of disorders associated with an excess of tachykinins.
